IDH1 and central nervous system cancer: Additionally, there is ongoing debate regarding the most effective adjuvant therapy for IDH-mutant gliomas, specifically whether temozolomide (TMZ) or the combination of procarbazine, lomustine, and vincristine (PCV) is superior [12–14].